2C-iP

2C-iP, also known as 4-isopropyl-2,5-dimethoxyphenethylamine or as Jelena or Momento, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally. The drug was first described by 2011 and was encountered as a novel designer drug by 2018.
== Use and effects == 2C-iP's dose is 8 to 25 mg orally and its duration is 8 to 12 hours. It is said that careful dose titration is necessary to avoid overdose. The drug is said to produce a strong sense of heightened awareness of the present moment, resulting in the nickname "Momento", among other effects.
== Interactions ==
== Pharmacology ==
=== Pharmacodynamics === 2C-iP shows affinity for the serotonin 5-HT2 receptors, including for the serotonin 5-HT2A receptor.
== Chemistry ==
=== Analogues === Analogues of 2C-iP include 2C-P, 2C-cP, 2C-iBu, 2C-tBu, 2C-D, 2C-E, 2C-T-4, and DOiP, among others.
== History == 2C-iP was first described in the scientific literature by Dmitri Ger and colleagues by 2011. It was encountered as a novel designer drug in Sweden in 2018.
== Society and culture ==
=== Legal status ===
==== Canada ==== As of October 31, 2016, 2C-iP is a controlled substance (Schedule III) in Canada.
==== United States ==== 2C-iP is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption. In addition, it may be considered scheduled as an isomer of 2C-P.
== See also == 2C (psychedelics)
== References ==
== External links == 2C-IP (Jelena, Momento) - Isomer Design The Main 2C-iP Thread - Bluelight 2C-IP Reports - Erowid Experience Vaults - Erowid
Wikipedia contributors, "2C-iP", Wikipedia, revision 1371213211, retrieved 21 November 2026, source, CC BY-SA 4.0.